Polisetti
Dharma R. Polisetti, High Point, NC US
Patent application number | Description | Published |
---|---|---|
20100113331 | Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors - The present invention provides imidazole derivatives of Formula (I-IV), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I-IV), and their use in treating human or animal disorders. The compounds of the invention inhibit protein tyrosine phosphatase 1B and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes and Type II diabetes. | 05-06-2010 |
20110077399 | Substituted Azole Derivatives as Therapeutic Agents - This invention provides azoles which may be useful as inhibitors of protein tyrosine phosphatases (PTPases). The present invention provides compounds of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds and their use in treating human or animal disorders. The compounds of the invention may be useful as inhibitors of protein tyrosine phosphatases and thus can be useful for the management, treatment, control and adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes, Type II diabetes. | 03-31-2011 |
20110092553 | Substituted Azole Derivatives, Compositions, and Methods of Use - The present invention provides azole derivatives of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I), and their use in treating human or animal disorders. The compounds of the invention can be useful as inhibitors of protein tyrosine phosphatases and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes and Type II diabetes. | 04-21-2011 |
20120196906 | Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors - The present invention provides imidazole derivatives of Formula (I-IV), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I-IV), and their use in treating human or animal disorders. The compounds of the invention inhibit protein tyrosine phosphatase 1B and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes and Type II diabetes. | 08-02-2012 |
Dharma Rao Polisetti, Greensboro, NC US
Patent application number | Description | Published |
---|---|---|
20110301158 | ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS - This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial. | 12-08-2011 |
Raja Polisetti, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20120116908 | Facilitating Electronic Auction of Prepayment of an Invoice - Embodiments for facilitating an electronic auction of prepayment of an invoice are disclosed. One method includes a supplier and a buyer approving the invoice with definite terms. The supplier electronically submits the invoice with proposed prepayment terms to an exchange platform. The exchange platform provides an electronic auction of the invoice with proposed prepayment terms to a plurality of bidders and receiving a bid from at least one of the plurality of bidders. Payment of the invoice between the winning bidder and the supplier is electronically facilitated if a winning bid is received. | 05-10-2012 |
20130191266 | FACILITATING ELECTRONIC AUCTION OF PREPAYMENT OF AN INVOICE - Embodiments for facilitating an electronic auction of prepayment of an invoice are disclosed. One embodiment includes a server for facilitating an electronic auction of prepayment of an invoice. For this embodiment, the server is operative to inform a supplier whether the invoice is available for meeting a defined cash need of the supplier after the invoice has been approved by the supplier and a buyer with definite terms, receive a prepayment offer from the buyer, and provide the prepayment offer to the supplier, provide the supplier with information to aid the supplier in determining whether to take the prepayment offer from the buyer, or submit the invoice with proposed prepayment terms to an exchange platform, electronically provide the invoice to the exchange platform server with proposed prepayment terms if the supplier decides to submit the invoice, wherein the exchange platform server facilitates an electronic auction of the invoice with proposed prepayment terms to a plurality of bidders and receive a bid from at least one of the plurality of bidders, and electronically facilitate payment of the invoice between the winning bidder and the supplier if a winning bid is received. | 07-25-2013 |
Satish Polisetti, Berkeley, CA US
Patent application number | Description | Published |
---|---|---|
20130145441 | CAPTCHA AUTHENTICATION PROCESSES AND SYSTEMS USING VISUAL OBJECT IDENTIFICATION - Systems and processes for performing user verification using an imaged-based CAPTCHA are disclosed. The verification process can include receiving a request from a user to access restricted content. In response to the request, a plurality of images may be presented to the user. A challenge question or command that identifies one or more of the displayed plurality of images may also be presented to a user. A selection of one or more of the plurality images may then be received from the user. The user's selection may be reviewed to determine the accuracy of the selection with respect to the challenge question or command. If the user correctly identifies a threshold number of images, then the user may be authenticated and allowed to access the restricted content. However, if the user does not correctly identify the threshold number of images, then the user may be denied access the restricted content. | 06-06-2013 |